Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01611779
Other study ID # 2011
Secondary ID
Status Recruiting
Phase Phase 4
First received May 29, 2012
Last updated June 4, 2012
Start date May 2012
Est. completion date August 2013

Study information

Verified date June 2012
Source Siesta Medical, Inc.
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The objective of this study is to assess the feasibility and safety of tongue suspension using the Siesta Medical Encore Tongue Suspension System for the treatment of obstructive sleep apnea (OSA).


Description:

Obstructive sleep apnea (OSA) has become a major health problem in the United States. With prevalence in middle-aged adults of 2-4% of the population, untreated OSA has been implicated in increased risk for cardiovascular disease, including hypertension and heart failure.

The first and most common treatment for OSA is continuous positive airway pressure (CPAP) treatment, utilized by an estimated 3 million Americans. CPAP is effective in reducing apnea-hypopnea index (AHI) is used properly. However, the nasal mask required for CPAP during sleep leads to poor acceptance and compliance rates. Published studies on CPAP have shown that only 58-8-% of patient accept CPAP therapy and further 65-90% of these patients exhibit long-term compliance with CPAP.

It is widely accepted that the region behind the tongue is a major site of collapse during obstructive sleep apnea. In fact there are many surgical procedures performed currently to address tongue based collapse. These include RF ablation of the tongue base, genioglossus advancement, hyoid suspension, maxillomandibular advancement, and tongue base suspension.

The current study is designed to evaluate the feasibility of tongue stabilization, and assess safety and treatment of the tongue stabilization.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date August 2013
Est. primary completion date August 2012
Accepts healthy volunteers No
Gender Both
Age group 20 Years to 65 Years
Eligibility Inclusion Criteria:

- Documented diagnosis of moderate obstructive sleep apnea (AHI 5-30/hour) measured within 12 months prior to the planned procedure

- Age >/= 20 and >/= 65

- Body Mass Index ,/= 32 (kg/m2)

- Patient offered CPAP and has refused of failed to continue CPAP treatment or is not compliant with CPAP

- Signed informed consent to participate in this study

Exclusion Criteria:

- Prior OSA surgery

- Active systemic infection

- Allergy to any medication used during implantation

- Previous history of neck or upper respiratory tract

- Significant dysphagia or speech disorder

Anatomical

- Identified obvious palatal stenosis

- Enlarged tonsils (3+)

- Anatomy unable to accommodate the implant

Other

- Other medical, social, or psychological problems that , in the opinion of the investigator, precludes the patient from receiving this treatment and the procedures and evaluations pre- and post-treatment

- Enrollment in another pharmacological or medical device study that may effect or bias the results of this clinical study

- Unable and/or not willing to comply with treatment follow-up requirements

- Pregnancy (Female subjects of childbearing potential must have a negative pregnancy test prior to enrollment

Study Design

Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Intervention

Device:
Encore Tongue Suspension System
The primary components of the Encore Tongue Suspension System consist of a suture passer, suspension line and bone screw.

Locations

Country Name City State
United States The Atlanta Snoring and Sleep Disorders Institute Atlanta Georgia

Sponsors (1)

Lead Sponsor Collaborator
Siesta Medical, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Ability to place the implant and stabilize the tongue Ability to place the implant and stibilize the tongue Up to 7 weeks after the procedure No
Primary Complications Evaluate safety of the device 3 months Yes
Secondary Apnea hypopnea index 0 to >30/hour (high value represents worse outcome) 3 and 12 months No
Secondary Functional Outcomes and Sleep Questionnaire (FOSQ) 0 to 120 (high value represents better outcome) 1, 3, 12 month No
Secondary Snoring Scale (VAS) 0 to 10 (high value represents worse outcome) 1 week; 1, 3, 12 months Yes
Secondary Epworth Sleeping Scale (ESS) 0 to 24 (high value represents worse outcome) 1, 3, 12 months No
See also
  Status Clinical Trial Phase
Recruiting NCT05857384 - Bioavailability, Bioequivalence and Tolerability of IHL-42X Compared to the Reference Drugs Phase 1
Recruiting NCT04547543 - Follow-up of Apneic Patients by Visio-consultation N/A
Recruiting NCT05371509 - Novel Myofunctional Water Bottle to Reduce OSA and Snoring Study N/A
Completed NCT02515357 - Mediterranean Diet/Lifestyle Intervention in Obstructive Sleep Apnea N/A
Completed NCT05582070 - Effect on Sleep of Surgical Treatment of Severe Nasal Obstruction N/A
Active, not recruiting NCT03189173 - Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea Phase 2
Completed NCT04084899 - The Effect of CPAP on Lung Hyperinflation in Patients With OSA
Completed NCT03032029 - Registry on the Treatment of Central and Complex Sleep-Disordered Breathing With Adaptive Servo-Ventilation
Recruiting NCT04028011 - Clinical Evaluation of a Wearable Technology for the Diagnosis of Sleep Apnoea
Recruiting NCT06047353 - Community Health Advocates for Motivating PAP Use in Our Neighborhoods. N/A
Completed NCT05253963 - Acute Effect of CPAP on Weight in Patients With Obstructive Sleep Apnea N/A
Recruiting NCT06029959 - Stroke and CPAP Outcome Study 3 N/A
Recruiting NCT06150352 - Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
Completed NCT03589417 - Postural Stability, Balance and Fall Risk in Patients With Obstructive Sleep Apnea
Recruiting NCT04335994 - ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing N/A
Withdrawn NCT04063436 - Evaluation of a New Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea N/A
Recruiting NCT05385302 - Sociological Determinants of Positive Airway Pressure Adherence in OSA Patients
Recruiting NCT04572269 - Metabolomics of Obstructive Sleep Apnea
Not yet recruiting NCT06467682 - 12-week Tele-exercise Program in Patients With OSA N/A
Withdrawn NCT04011358 - Retinal Vein Occlusion and Obstructive Sleep Apnea: A Case Control Study N/A